We found that the drug combination of rapamycin and AICAR had a strong additive effect in decreasing cell proliferation, increasing cell apoptosis, and abolishing Akt and HIF2α expression in RCC cell lines and primary ccRCC cells isolated from kidney cancer patient. Here, EPAS1 is linked to renal cell carcinoma.